엠에프씨

432980KOSDAQ기초 의약물질 제조업

57.8 / 100

Reference Date: 2026-06-10

Financial Score22.5 / 40

News Sentiment21.3 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Plunged 18.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

MFC is a specialized company in the development and production of active pharmaceutical ingredients (APIs) and key materials (e.g., KSM, PI), expanding its business across generic drugs and improved new drug materials. Key products include APIs for treating hypertension and hyperlipidemia, as well as improved new drug materials (e.g., MFC-TM001, MFC-GM001), leveraging patented crystal form and salt development technologies to enhance market competitiveness.

Number of Employees

65people

Average Salary

64.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

28.59Industry Average 27.713.0Point

Higher than industry avg (caution)

PBR

0.84Industry Average 1.747.0Point

Half of industry avg (excellent)

ROE

2.82Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

0.40Industry Average 6.628.0Point

Half of industry avg (excellent)

Trend 2024~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲0.9% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼79.7% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -1.2% (improving, 2yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
엠에프씨, GLP-1 ‘오포글리프론’ 제제 기술 확보
엠에프씨가 AI 기반 연구를 통해 차세대 당뇨·비만 치료제 핵심 성분인 오포글리프론 기술을 확보하여 시장 선점에 유리한 위치를 차지했다.

Detailed Momentum

52-week position3.0Point

52w lower range (21%)

Current 2,945Won52-week high 4,24052-week low 2,600

1-month return0.0Point

1m -18.19% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-04
Neutral주식등의대량보유상황보고서(일반)2026-06-04
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-27
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-27
Neutral주식등의대량보유상황보고서(일반)2026-05-27